UNSPSC 51284125: Cefditoren pivaloyloxymethyl ester

This classification denotes a cephalosporin antibiotic with the molecular formula C25H28N6O7S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 78THA212DH, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(((2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-((1z)-2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6r,7r)-, but more generally known as cefditoren pivaloyloxymethyl ester, which bears US NIH Compound Identifier 444006.

UNSPSC 51284125 Cefditoren pivaloyloxymethyl ester is a Commodity code for a specific pharmaceutical active ingredient, but recent state and local procurement activity under this code shows little alignment with the narrow scope of the coded product itself. The most recent opportunities posted under this UNSPSC include purchases of broad pharmaceutical supplies—antibiotics such as Doxycycline Hyclate and Ciprofloxacin Hydrochloride, as well as naloxone and drug deactivation systems—rather than cefditoren pivaloyloxymethyl ester specifically. State and local issuing bodies accessing this code appear to be using piggyback and cooperative purchasing vehicles to procure pharmaceutical warehousing and emergency medical supplies through established consortia and competitive bidding processes, with contracts awarded to vendors meeting lowest-price-responsive-and-responsible criteria.

Activity under the code is sparse and geographically limited. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC for $2,999,999.11 over a 12-month initial term with two renewal options, posted August 28, 2026 with response deadline September 11, 2026, under an Invitation for Bid process. Seminole County, Florida solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to Sanford, posted June 30, 2026 with response deadline July 26, 2023. The code shows minimal recent activity specific to cefditoren pivaloyloxymethyl ester itself; firms pursuing pharmaceutical supply contracts with state and local health agencies should verify code assignment at the pre-bid stage to ensure alignment with actual scope before committing resources.